Guardion Health Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Guardion Health Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q2 2024.
  • Guardion Health Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $10.3M.
  • Guardion Health Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $6.37M.
  • Guardion Health Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $158K.
  • Guardion Health Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9M, a 39.7% increase from 2021.
  • Guardion Health Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$24.7M, a 189% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.37M $10.3M +$11.5M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$5.12M -$4.75M -$5.28M -990% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 $158K $425K +$12.9M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$12.7M $373K +$1.2M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$13.9M -$1.17M -$4.83M -132% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$9.09M $533K +$5.83M Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$14.9M -$12.5M +$2.07M +14.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$17M -$823K +$2.19M +72.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$19.2M $3.66M +$8.2M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$27.4M -$5.3M -$2.63M -98.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$24.7M -$14.5M -$11.1M -330% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$13.6M -$3.01M -$871K -40.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$12.7M -$4.54M -$3.83M -542% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$8.89M -$2.67M -$323K -13.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$8.57M -$3.37M +$682K +16.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$9.25M -$2.14M +$242K +10.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.5M -$707K +$2.34M +76.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$11.8M -$2.35M -$962K -69.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$10.9M -$4.06M -$2.58M -175% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$8.3M -$2.39M -$237K -11% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$8.06M -$3.05M -$1.24M -68.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$6.82M -$1.39M +$948K +40.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$7.77M -$1.48M +$720K +32.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$8.49M -$2.15M -$564K -35.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$7.92M -$1.81M -$954K -111% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-13
Q1 2018 -$6.97M -$2.33M -$1.66M -249% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-13
Q4 2017 -$5.31M -$2.2M +$111K +4.83% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 -$5.42M -$1.58M -$443K -38.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$4.97M -$856K +$495K +36.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$5.47M -$669K +$280K +29.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$5.75M -$2.31M Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$1.14M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$1.35M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$949K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.